Literature DB >> 19660715

The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34+ cord blood hematopoietic progenitor cells.

Rose C Beck1, Mallika Padival, David Yeh, Justine Ralston, Kenneth R Cooke, John B Lowe.   

Abstract

Notch receptor signaling is required for T cell development, but its role in natural killer (NK) cell development is poorly understood. We compared the ability of the 5 mammalian Notch ligands (Jagged1, Jagged2, Delta1, Delta3, or Delta4) to induce NK cell development from human hematopoietic progenitor cells (HPCs). CD34(+) HPCs were cultured with OP9 stromal cell lines transduced with 1 of the Notch ligands or with OP9 stromal cells alone, in the presence of IL-7, Flt3L, and IL-15. Differentiation and expansion of CD56(+)CD3(-) cells were greatly accelerated in the presence of Jagged2, Delta-1, or Delta-4, versus culture in the absence of ligand or in the presence of Jagged1 or Delta3. At 4 weeks, cultures containing Jagged2, Delta1, or Delta4 contained 80% to 90% NK cells, with the remaining cells being CD33(+) myelogenous cells. Notch-induced NK (N-NK) cells resembled CD56(bright) NK cells in that they were CD16(-), CD94(-), CD117(+), and killer immunoglobulin-like receptors (KIR(-)). They also expressed NKp30, NKp44, NKp46, 2B4, and DNAM-1, with partial expression of NKG2D. The N-NK cells displayed cytotoxic activity against the K562 and RPMI-8226 cell lines, at levels similar to activated peripheral blood (PB) NK cells, although killing of Daudi cells was not present. N-NK cells were also capable of interferon (IFN)-gamma secretion. Thus, Notch ligands have differential ability to induce and expand immature, but functional, NK cells from CD34(+) HPCs. The use of Notch ligands to generate functional NK cells in vitro may be significant for cellular therapy purposes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19660715      PMCID: PMC2730186          DOI: 10.1016/j.bbmt.2009.06.002

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  46 in total

1.  Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.

Authors:  J J Campbell; S Qin; D Unutmaz; D Soler; K E Murphy; M R Hodge; L Wu; E C Butcher
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

2.  Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.

Authors:  Jacob Hanna; Pamela Bechtel; Yufeng Zhai; Fadi Youssef; Karen McLachlan; Ofer Mandelboim
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

3.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

Authors:  J S Miller; V McCullar
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

4.  Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.

Authors:  D Pende; C Cantoni; P Rivera; M Vitale; R Castriconi; S Marcenaro; M Nanni; R Biassoni; C Bottino; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  2001-04       Impact factor: 5.532

5.  Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.

Authors:  S Sivori; S Parolini; E Marcenaro; R Castriconi; D Pende; R Millo; A Moretta
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

6.  Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction.

Authors:  Roberta Castriconi; Alessandra Dondero; Maria Valeria Corrias; Edoardo Lanino; Daniela Pende; Lorenzo Moretta; Cristina Bottino; Alessandro Moretta
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

7.  Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro.

Authors:  Ross N La Motte-Mohs; Elaine Herer; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

8.  HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.

Authors:  Ennio Carbone; Paola Neri; Maria Mesuraca; Mariateresa T Fulciniti; Takemi Otsuki; Daniela Pende; Veronika Groh; Thomas Spies; Giuditta Pollio; David Cosman; Lucio Catalano; Pierfrancesco Tassone; Bruno Rotoli; Salvatore Venuta
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

9.  Notch ligands Delta 1 and Jagged1 transmit distinct signals to T-cell precursors.

Authors:  Sophie M Lehar; James Dooley; Andrew G Farr; Michael J Bevan
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

10.  Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation.

Authors:  A C Jaleco; H Neves; E Hooijberg; P Gameiro; N Clode; M Haury; D Henrique; L Parreira
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  22 in total

Review 1.  Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy.

Authors:  Martha Luevano; Alejandro Madrigal; Aurore Saudemont
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 2.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

3.  Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.

Authors:  Frank Cichocki; Martin Felices; Valarie McCullar; Steven R Presnell; Ahmad Al-Attar; Charles T Lutz; Jeffrey S Miller
Journal:  J Immunol       Date:  2011-11-14       Impact factor: 5.422

4.  Notch ligand delta-like 4 regulates development and pathogenesis of allergic airway responses by modulating IL-2 production and Th2 immunity.

Authors:  Sihyug Jang; Matthew Schaller; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

5.  Notch signaling defects in NK cells in patients with cancer.

Authors:  Gulnur K Zakiryanova; Elena Kustova; Nataliya T Urazalieva; Emile T Baimukhametov; Valeriy A Makarov; Gulmariya M Turaly; Galina V Shurin; Zarema M Biyasheva; Narymzhan N Nakisbekov; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2020-10-21       Impact factor: 6.968

6.  Notch signaling at later stages of NK cell development enhances KIR expression and functional maturation.

Authors:  Martin Felices; Dave E M Ankarlo; Todd R Lenvik; Heather H Nelson; Bruce R Blazar; Michael R Verneris; Jeffrey S Miller
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

7.  Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development.

Authors:  Ansel P Nalin; Jesse J Kowalski; Alexander C Sprague; Blaire K Schumacher; Adam G Gerhardt; Youssef Youssef; Kiran V Vedantam; Xiaoli Zhang; Christian W Siebel; Emily M Mace; Michael A Caligiuri; Bethany L Mundy-Bosse; Aharon G Freud
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

8.  Generation of cell-derived matrices that support human NK cell migration and differentiation.

Authors:  Barclay J Lee; Everardo Hegewisch Solloa; Michael J Shannon; Emily M Mace
Journal:  J Leukoc Biol       Date:  2020-05-11       Impact factor: 4.962

9.  Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface.

Authors:  Vanda Juranic Lisnic; Marina Babic Cac; Berislav Lisnic; Tihana Trsan; Adam Mefferd; Chitrangada Das Mukhopadhyay; Charles H Cook; Stipan Jonjic; Joanne Trgovcich
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

10.  Withaferin A induces cell death and differentiation in multiple myeloma cancer stem cells.

Authors:  Mark E Issa; Muriel Cuendet
Journal:  Medchemcomm       Date:  2016-11-17       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.